Bayer Sells Plasma Unit to U.S. Investors
606574
Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for &#36;590 million in cash and stock to the private U.S. investment groups Cerberus Capital Management and Ampersand Ventures.
217896
FRANKFURT Bayer said Monday that it had formed a partnership with Schering-Plough to market some of its biggest drugs in the United States.
2932
According to fdi.gov.cn: According to Germany-based Bayer Group, it has laid down a latest investment plan for 2009 in China. The plan will enable 1.8 billion euro of additional investment in Bayer's new synthetic material production project in Shanghai.
557886
The Swedish company Gambro AB will sell a division to an El Segundo company for $3.05 billion in cash. Gambro Healthcare US, the division being sold, operates clinics for patients undergoing kidney dialysis and has 565 clinics and 43,200 patients.
348152
The German drug maker Bayer said its third-quarter profit fell 35 percent on costs related to its acquisition of a rival, Schering, but its performance still exceeded analystsÂ expectations. Bayer earned 320 million euros ($419 million) in the three months through September, down from 493 million euros a year earlier. Sales rose 26 percent, to 7.78 billion euros ($10.2 billion). The company, based in Leverkusen, said it booked special charges totaling 139 million euros ($182 million) in the quarter, with 106 million euros ($139 million) of that mostly attributable to the integration of its health care unit with Schering. Bayer bought Schering in June in a deal worth nearly 16.9 billion euros ($22 billion) to strengthen its health care business. The company said its health care unit was Âthe principal growth engine for BayerÂs business in the third quarter,Â with sales climbing 73 percent, to 3.48 billion euros ($4.56 billion).
303420
The Boston Scientific Corporation, the maker of medical devices, said on Thursday that it had agreed to sell its fluid management and venous access businesses for $425 million to the private equity firm Avista Capital Partners.
293928
Investors in Germany's Bayer will get one share in chemicals and polymers spin-off Lanxess for every 10 Bayer shares held, a German newspaper said, valuing Lanxess at nearly 1.6 billion euros ($1.97 billion). ...
215660
Gambro AB said Tuesday that it will sell its U.S. dialysis clinics to DaVita Inc.
624076
The Dutch retail giant Ahold said Tuesday it had finalised the sale of its US division US Foodservice to private equity funds Clayton, Dubilier, Rice and Kohlberg Kravis Roberts for 7.1 billion dollars (5.2 billion euros).
564798
Two private equity groups -- The Carlyle   Group CYL.UL and Apax Partners -- said on Sunday they have   signed an agreement to sell healthcare marketing services firm   MediMedia USA Inc. to Vestar Capital Partners.
434669
German chemical and drug maker Bayer AG and New Jersey pharmaceutical company Schering-Plough Corp. announced an alliance Monday under which Schering-Plough will distribute Bayer's primary care pharmaceutical products in the United States.
537343
An experimental thrombosis pill from   Bayer AG BAYG.DE, seen by analysts as the German group's most   important pipeline asset, has produced promising results in two   clinical trials, researchers said on Tuesday.
310083
Germany&#39;s Roechling family completed the sale of its stake in weapons-maker Rheinmetall AG to institutional investors for 561 million euros ($743 million), people familiar with the transaction said.
63189
Bayer forged an alliance for its struggling pharmaceuticals business with American drug manufacturer Schering-Plough yesterday, cutting costs and marking another step in the German company&#39;s transformation.
8792
Spectrum Pharmaceuticals  said on Friday U.S. regulators have approved its generic version of Bayer's   Cipro antibiotic, triggering a &#36;750,000 equity investment by one of its partners.
230256
Bayer AG has agreed to sell its plasma products business to US investors Cerberus Capital Management and Ampersand Ventures for US$590 million (euro445 million) in cash and stock, the German drug and chemical company said Monday.
727866
German chemical and drug maker Bayer AG announced Monday it has entered a strategic alliance with the Schering-Plough Corporation that will have the New Jersey-based company market and distribute Bayer&#39;s primary care pharmaceutical products in the United